Angiogenic Gene Therapy for Refractory Angina: Results of the Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (EXACT) Phase 2 Trial
EUROPEAN HEART JOURNAL（2023）
Key words
Cardiovascular Risk Assessment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined